Eugen Merkul
Head of Chemistry
LinXis Pharmaceuticals
The Netherlands
Biography
Eugen Merkul has completed his PhD with summa cum laude from University of Düsseldorf/Germany and postdoctoral studies from University of Antwerp/Belgium, followed by industrial experience at German and Dutch companies. He is the Head of Chemistry of LinXis B.V., an innovative Dutch biotech company developing a proprietary ADC (antibody-drug conjugates) platform technology. He is author/coauthor of 23 papers in reputed peer-reviewed journals and inventor/coinventor of 10 patent applications.
Research Interest
Chemistry